LDLR p.Val436Ala

Variant summary

Our verdict is Uncertain significance.
+4 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 4 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_SupportingO6_SupportingO7_SupportingO8_Supporting

The NM_000527.5(LDLR):c.1307T>C (p.Val436Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene LDLR is a known oncogene (CancerMine: 2 oncogene citations). The variant allele was found at a cumulative frequency of 0.00000806 (AC=13) in the gnomAD database across 1,613,722 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000488. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV004087471: A functional study detected partial reduction of LDLR protein expression in cells derived from a patient heterozygous for this alteration" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.V436E: Likely_pathogenic (ClinVar VariationId 1518023, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.V436M: Uncertain_significance (ClinVar VariationId 1172265, 1 star)

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

LDLR
NM_000527.5 missense

Scores

7
8
4

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:16U:1

Conservation

PhyloP100: 6.06

Publications

3 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
LDLR Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 1
    Inheritance: SD, AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Natera
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
MIR6886 (HGNC:50121): (microRNA 6886) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000527.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 4 points.

O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000005 — very rare (O3 supporting [+1])
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 33 pathogenic, 0 benign (OR vs. background: 335.0); Variant does not impact splicing — splice-hotspot path not applicable
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 0.61 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

LDLR NM_000527.5
MANE Select
HGVSc / HGVSpc.1307T>Cp.Val436Ala
Exon rankExon 9 of 18
missense
Prot: NP_000518.1UniProt: P01130-1
LDLR NM_001195798.2
HGVSc / HGVSpc.1307T>Cp.Val436Ala
Exon rankExon 9 of 18
missense
Prot: NP_001182727.1UniProt: P01130-5
LDLR NM_001195799.2
HGVSc / HGVSpc.1184T>Cp.Val395Ala
Exon rankExon 8 of 17
missense
Prot: NP_001182728.1UniProt: P01130-4

Ensembl Transcripts

LDLR ENST00000558518.6
TSL:1MANE Select
HGVSc / HGVSpc.1307T>Cp.Val436Ala
Exon rankExon 9 of 18
missense
Prot: ENSP00000454071.1UniProt: P01130-1
LDLR ENST00000252444.10
TSL:1
HGVSc / HGVSpc.1565T>Cp.Val522Ala
Exon rankExon 9 of 18
missense
Prot: ENSP00000252444.6UniProt: J3KMZ9
LDLR ENST00000558013.5
TSL:1
HGVSc / HGVSpc.1307T>Cp.Val436Ala
Exon rankExon 9 of 18
missense
Prot: ENSP00000453346.1UniProt: P01130-5

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0000132
AC:2
Hom:0
AN:152042
Cov:29
GnomAD2 exomes
AF: 0.0000119
AC:3
AN:251266
GnomAD4 exome
AF: 0.00000753
AC:11
Hom:0
AN:1461680
Cov:33
GnomAD4 genome
AF: 0.0000132
AC:2
Hom:0
AN:152042
Cov:29
TOPMed (Bravo)
AF: 0.00000378
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000377
AC:2
Hom:0
AN:53064
Showing 6 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
Epi25
(Epilepsy)
0.0000238 141958 0.0000150 166888
SCHEMA
(Schizophrenia)
0.0000144 169396 0.00000802 1124680
Showing 2 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
6
-
-
Familial hypercholesterolemia (6)
4
1
-
Hypercholesterolemia, familial, 1 (5)
5
-
-
not provided (5)
1
-
-
Cardiovascular phenotype (1)

Computational Scores

AlphaGenome AVI
Pathogenic22
AlphaMissense
Benign0.17
BayesDel_addAF
Pathogenic0.28D
BayesDel_noAF
Pathogenic0.23
CADD
Pathogenic27
DANN
Uncertain1.0
DEOGEN2
Uncertain0.75D
Eigen
Benign0.18
Eigen_PC
Uncertain0.27
FATHMM_MKL
Pathogenic0.98D
FuncVEP CTI
Pathogenic0.55
GPN-Star LLR
N/A-6.9
GPN-Star score
N/A6.9
LIST_S2
Benign0.81T
M_CAP
Pathogenic0.61D
MetaRNN
Pathogenic0.92D
MetaSVM
Uncertain0.59D
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Benign1.2L
PhyloP100
Uncertain6.1
popEVE
Benign-3.2
PrimateAI
Uncertain0.51T
PROVEAN
Uncertain-3.6D
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.1
REVEL
Pathogenic0.75
Sift
Uncertain0.0020D
Sift4G
Uncertain0.0090D
Varity_R
N/A0.62
VESM-3B
Benign-7.2
Showing 30 of 30 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

1 no calibration
Protein level
LDLR missense variant effects on LDL uptake.
The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR.
Gene
LDLR
Assay type
Flow cytometry assay
Mechanism
Gain or loss of function
Model system
Immortalized human cells
Score
0.926 · p.Val436Ala (assay numbering)
No calibration data
This score is at approximately the 51th percentile of all variants tested in this assay.
This score has not been calibrated against ACMG evidence — shown for context only, not as clinical evidence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.